Financial Performance and Growth - The company achieved steady growth in revenue and profitability in 2023, with financial business remaining stable and asset quality improving[10] - The company's total assets reached RMB 3,514.83 billion at the end of 2023, a year-on-year increase of 1.29%, with annual revenue of RMB 379.60 billion, up 3.76% year-on-year, and net profit attributable to ordinary shareholders of RMB 6.193 billion, a year-on-year increase of 1.04%[13] - Total revenue for 2023 reached RMB 37,959,798 thousand, a 3.8% increase from RMB 36,585,722 thousand in 2022[19] - Net profit attributable to ordinary shareholders was RMB 6,192,972 thousand in 2023, slightly up from RMB 6,128,954 thousand in 2022[19] - The company's average return on equity was 12.99% in 2023, with a proposed dividend of HKD 0.50 per share[13] - The company's diluted earnings per share were RMB 1.33 in 2023, with an average return on assets of 1.98% and an average return on equity of 12.99%[17] - The company's asset-liability ratio decreased from 84.89% in 2022 to 83.62% in 2023, with net assets per share increasing from RMB 10.49 in 2022 to RMB 11.61 in 2023[18] - The group's revenue for 2023 reached RMB 37,959.798 million, a 3.76% increase compared to the previous year[36][38] - Net profit attributable to ordinary shareholders of the company for 2023 was RMB 6,192.972 million, a 1.04% increase compared to the previous year[36] - The company's total assets increased by 1.29% to RMB 351.48 billion as of December 31, 2023, compared to RMB 346.99 billion in the previous year[80] - The company's cash and cash equivalents increased significantly by 18.54% to RMB 18.85 billion as of December 31, 2023[80] - The company's total liabilities decreased by RMB 640.439 million (0.22%) to RMB 293,913.636 million as of December 31, 2023, with interest-bearing bank and other financing accounting for 86.98% of total liabilities, an increase of 1.65 percentage points compared to the previous year[141][142] - The company's property, plant, and equipment balance was RMB 23,513.055 million, including RMB 18.2 billion for equipment operations and RMB 3.3 billion for hospital buildings and medical equipment[139] - The company's investment in joint ventures and associates amounted to RMB 9,105.237 million, including RMB 5,093.862 million in equity investments in provincial asset management companies[139] - The company's financial assets measured at fair value through profit or loss totaled RMB 8,841.595 million, including RMB 3.22 billion in interest-bearing assets and RMB 2.85 billion in other debt investments[140] - The company's total assets under asset-backed securities/notes decreased by 71.83% to RMB 1,649 million as of December 31, 2023, compared to RMB 5,853 million in the previous year[137] - The company's self-held portion of asset-backed securities/notes decreased by 58.55% to RMB 369.172 million as of December 31, 2023, compared to RMB 890.572 million in the previous year[137][138] - The company's deferred tax assets amounted to RMB 6,052.352 million, primarily due to timing differences between accounting and tax treatments[139] - The company's prepayments and other receivables stood at RMB 4,374.919 million, mainly consisting of prepayments to suppliers for machinery and equipment[139] - The company's restricted deposits amounted to RMB 3,149.062 million as of December 31, 2023[139] - The total interest-bearing bank and other financing of the company amounted to RMB 255,636,145 thousand as of December 31, 2023, an increase of 1.71% compared to the end of the previous year[144] - The proportion of current interest-bearing bank and other financing increased to 51.79% as of December 31, 2023, up from 49.12% at the end of the previous year, mainly due to a reduction in the issuance scale of long-term bonds overseas[145][146] - The proportion of unsecured interest-bearing bank and other financing decreased to 82.13% as of December 31, 2023, down from 84.95% at the end of the previous year, as the company obtained more low-cost funds through asset pledges[147] - Bank loans accounted for 60.87% of the total interest-bearing bank and other financing as of December 31, 2023, an increase of 15.91% compared to the end of the previous year, reflecting the company's deepening cooperation with banks[149] - Domestic financing accounted for 84.59% of the total interest-bearing bank and other financing as of December 31, 2023, an increase of 3.73% compared to the end of the previous year, as the company balanced domestic and overseas financing channels[150][151] - RMB-denominated financing accounted for 81.35% of the total interest-bearing bank and other financing as of December 31, 2023, an increase of 4.56% compared to the end of the previous year, as the company actively promoted RMB financing both domestically and internationally[152][153] - Indirect financing accounted for 69.67% of the total interest-bearing bank and other financing as of December 31, 2023, an increase of 15.73% compared to the end of the previous year, as the company optimized its financing structure and increased indirect financing[155] - The total equity of the company amounted to RMB 57,569,600 thousand as of December 31, 2023, an increase of 9.78% compared to the end of the previous year, driven by steady profit growth and the successful listing of Hongxin Construction[156] - Total equity increased by 9.78% to RMB 57.57 billion in 2023, compared to RMB 52.44 billion in 2022[157] - The company's ordinary shareholders' equity rose by 10.72% to RMB 50.10 billion in 2023, up from RMB 45.25 billion in 2022[157] - Non-controlling interests surged by 43.39% to RMB 5.90 billion in 2023, compared to RMB 4.11 billion in 2022[157] - Perpetual securities decreased by 48.91% to RMB 1.57 billion in 2023, down from RMB 3.08 billion in 2022[157] - The company proposed a special dividend in the form of a distribution of approximately 160 million Hongxin Construction shares, representing about 5% of the total issued shares of Hongxin Construction as of December 6, 2023[160] - The total dividend payable for the special dividend in kind was approximately RMB 664 million, based on the closing price of Hongxin Construction shares on December 29, 2023[160] - The listing of Hongxin Construction on the Hong Kong Stock Exchange on May 25, 2023, resulted in an increase of approximately RMB 870 million in the equity attributable to ordinary shareholders of the company[161] - The company updated its medium-term note and perpetual securities program on July 24, 2023, allowing for the issuance of up to USD 4 billion in notes and/or perpetual securities[165] - The company issued and outstanding convertible bonds as of December 31, 2023, include a 250 million zero-coupon bond due in 2026[166][167] - The net proceeds from the 296.6 million, with a net conversion price of approximately HK250 million bond issuance were approximately 10.01 per share[167] - As of December 31, 2023, the outstanding principal amount of the 290 million after redeeming 250 million bond remained at $250 million as of December 31, 2023[167] - If all convertible bonds were fully converted, the company would issue 569,336,712 shares, representing approximately 13.19% of the issued share capital as of December 31, 2023[170] - The conversion of all convertible bonds would dilute the shareholding percentage of major shareholders, with China National Chemical Corporation's stake decreasing from 21.31% to 18.83%[171] - The company's credit ratings remained unchanged in 2023, and it has sufficient cash flow and bank credit lines to fully repay the convertible bonds at maturity[173] - The implied internal rate of return for the convertible bonds issued on July 8, 2020, and June 15, 2021, indicates that bondholders will receive equally favorable economic returns whether they choose to convert or redeem the bonds by the end of 2023 to 2025. The corresponding stock prices are HKD 6.59 for 2023 and 2024, and HKD 8.94, 9.12, and 9.30 for 2023, 2024, and 2025, respectively[174] - The conversion prices for the convertible bonds issued in July 2020 and June 2021 were adjusted to HKD 6.48 and HKD 8.35 per share, respectively, due to the payment of special dividends on January 22, 2024. If all conversion rights are exercised, the company will issue 579,227,090 shares[175] - The company's asset-liability ratio was 83.62% as of December 31, 2023, compared to 84.89% in the previous year, reflecting a slight improvement in capital management[177][178] - The risk asset-to-equity ratios for the company's financing leasing subsidiaries were 4.58, 3.49, 1.57, and 4.34 as of December 31, 2023, all of which comply with regulatory requirements[179][180][181][182] - The company's capital expenditure for 2023 was RMB 2,880.915 million, primarily used for property, plant, and equipment additions, as well as external equity investments[183] Credit Ratings and ESG Performance - Far East Horizon's credit rating was confirmed as "BBB-" by S&P Global Ratings with a "stable" outlook, and its standalone credit profile (SACP) was upgraded to "bbb-"[10] - The company received an "A" rating from MSCI for ESG for two consecutive years, with its sustainable financing framework achieving the highest score among Asian financial institutions by Moody's and Fitch[10] Industrial Operations and Market Expansion - Far East Horizon's industrial operations saw breakthroughs, with Hongxin Construction successfully spinning off and listing, and continued expansion in overseas markets[10] - The company's healthcare business, Hongxin Health, returned to normal operating conditions, with operational efficiency continuously improving[10] - Far East Horizon operates in multiple sectors including healthcare, tourism, construction, machinery, chemicals, electronics, consumer goods, logistics, and urban utilities[7] - The company has established a nationwide service network with offices in major cities such as Beijing, Shanghai, Shenzhen, and Chengdu[8] - The company's headquarters is located in Hong Kong, with business operation centers in Shanghai, Tianjin, and Guangzhou[8] - Far East Horizon was listed on the Hong Kong Stock Exchange on March 30, 2011, under the stock code 03360[8] - Far East Horizon has been recognized in the Fortune China 500 and Forbes Global 2000 rankings[7] - The industrial operation segment achieved a total revenue of RMB 14.739 billion in 2023, a year-on-year increase of 11.38%, with its revenue contribution ratio rising from 36.02% to 38.68%[12] - Hongxin Jianfa, a leading equipment operation service provider in China, expanded its overseas market and increased its total revenue to RMB 9.611 billion in 2023, a year-on-year growth of 22.00%, with adjusted annual profit reaching RMB 1.043 billion, up 10.65% year-on-year[12] - Hongxin Jianfa's aerial work platform management scale reached 177,600 units by the end of 2023, ranking first in Asia and top three globally, with material asset management scale of approximately 2.28 million tons, maintaining domestic leadership[12] - Hongxin Health achieved a total revenue of RMB 4.238 billion in 2023, a year-on-year increase of 15.53%, with annual profit surging 252.75% year-on-year to RMB 172 million[12] - The company expanded its overseas market with new outlets in Malaysia and Indonesia, steadily advancing its international business[33] - The company's financial services (interest income) increased by 3.64% to RMB 22,467.103 million, while consulting services (fee income) decreased by 50.82% to RMB 896.331 million[39][40] - Industrial operations revenue increased by 11.38% to RMB 14.739 billion, with Hongxin Construction contributing RMB 9.611 billion (up 22.00%) and Hongxin Health contributing RMB 4.238 billion (up 15.53%)[41] - Non-leasing business accounted for 46.51% of total revenue (pre-tax), with new business directions like inclusive finance and commercial factoring contributing 5.48% of interest income[41] - Interest income from financial services increased by 3.64% to RMB 22.467 billion, accounting for 58.97% of total revenue (pre-tax)[42] - The average yield on interest-earning assets rose to 8.24% in 2023, up 0.24 percentage points from 8.00% in 2022[46] - Interest income from new business directions (inclusive finance, commercial factoring, and asset business) increased by 12.09% to RMB 2.087 billion, with an average yield showing steady growth[44] - Service fee income from consulting services decreased by 50.82% to RMB 896.331 million, accounting for 2.35% of total revenue (pre-tax)[48] - Sales costs increased by 10.10% to RMB 19.959 billion, with financial and consulting division costs rising by 10.82% to RMB 9.982 billion[52] - Hongxin Construction's operating costs increased by 23.28% to RMB 5.849 billion, while Hongxin Health's operating costs rose by 13.13% to RMB 3.473 billion[52] - Financial and consulting division costs increased by 10.82% to RMB 9,982,081 thousand in 2023, accounting for 50.01% of total sales costs[54][57] - Industrial operations division costs rose by 9.39% to RMB 9,976,734 thousand in 2023, with equipment operation costs surging 23.28% to RMB 5,849,180 thousand[54][59] - The company's gross profit decreased by 2.48% to RMB 18,000,983 thousand in 2023, with gross margin dropping from 50.45% to 47.42%[60] - Net interest income declined by 1.46% to RMB 12,485,022 thousand in 2023, while net interest spread increased by 4 basis points to 3.98%[62][64] - Industrial operations division gross profit grew 15.80% to RMB 4,762,537 thousand in 2023, with hospital operations gross profit surging 27.83% to RMB 765,180 thousand[65] - The company's average cost rate for interest-bearing liabilities increased to 4.26% in 2023, up from 4.06% in 2022[56][57] - Interest expense rose 10.82% to RMB 9,982,081 thousand in 2023, outpacing the 3.64% growth in interest income[62] - Equipment operation gross profit increased 20.06% to RMB 3,761,401 thousand in 2023, accounting for 78.98% of industrial operations gross profit[65] - Other income/earnings decreased by 21.55% to RMB 1,559,591 thousand in 2023, with gains from equity and debt investments surging 163.97% to RMB 507,929 thousand[66] - The company's average balance of interest-bearing liabilities increased to RMB 234,089,521 thousand in 2023, up from RMB 221,672,148 thousand in 2022[56] - Government subsidies for the period amounted to approximately RMB 160 million, including VAT deduction benefits, enterprise development subsidies, and government support funds[67] - Sales and administrative expenses increased by 19.59% to RMB 8,121,968 thousand, driven by market expansion strategies[68] - Other expenses decreased by 86.43% to RMB 55,090 thousand, with significant reductions in exchange losses and bank fees[69] - Financial costs decreased slightly by 1.59% to RMB 1,037,956 thousand, primarily related to financing costs for the industrial operations division[70] - Pre-provision profit decreased by 14.66% to RMB 10,614,851 thousand, impacted by rising financing costs and reduced gains from off-balance sheet assets[71] - Asset provisions decreased by 91.05% to RMB 189,591 thousand, with significant reversals in fixed asset provisions due to improved market conditions[72] - Income tax expenses decreased by 5.66% to RMB 3,508,237 thousand, mainly due to a reduction in cross-border withholding taxes[74] - Net profit attributable to ordinary shareholders increased by 1.04% to RMB 6,192,972 thousand, with basic earnings per share rising by 0.68% to RMB 1.47[75][76] - Total assets increased by 1.29% to RMB 351,483,236 thousand, while interest-earning assets decreased by 0.56% to RMB 269,084,739 thousand[79] - The company's total assets increased by 1.29% to RMB 351.48
远东宏信(03360) - 2023 - 年度财报